Your email has been successfully added to our mailing list.

×
0 0.000610687022900859 0.000305343511450321 0.00114503816793897 0.000438931297709958 0.00045801526717559 0.000343511450381801 -0.000992366412213706
Stock impact report

Bio-Rad OKs $250M share buyback plan [Seeking Alpha]

Bio-Rad Laboratories, Inc. Class A (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report
Company Research Source: Seeking Alpha
Bio-Rad OKs $250M share buyback planCiting a healthy balance sheet and cash flow, the board of Bio-Rad Laboratories (BIO+0.2%)authorizes the repurchase of up to $250M of its outstanding common stock. The new program supersedes the old one.Now read:FDA grants priority review status to Kyowa Hakko Kirin's BLA for Mogamulizumab for the treatment of CTCL » Show less Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BIO alerts
Opt-in for
BIO alerts

from News Quantified
Opt-in for
BIO alerts

from News Quantified